Literature DB >> 8771234

Structure and function of tetanus and botulinum neurotoxins.

C Montecucco1, G Schiavo.   

Abstract

Tetanus and botulinum neurotoxins are produced by Clostridia and cause the neuroparalytic syndromes of tetanus and botulism. Tetanus neurotoxin acts mainly at the CNS synapse, while the seven botulinum neurotoxins act peripherally. Clostridial neurotoxins share a similar mechanism of cell intoxication: they block the release of neurotransmitters. They are composed of two disulfide-linked polypeptide chains. The larger subunit is responsible for neurospecific binding and cell penetration. Reduction releases the smaller chain in the neuronal cytosol, where it displays its zinc-endopeptidase activity specific for protein components of the neuroexocytosis apparatus. Tetanus neurotoxin and botulinum neurotoxins B, D, F and G recognize specifically VAMP/ synaptobrevin. This integral protein of the synaptic vesicle membrane is cleaved at single peptide bonds, which differ for each neurotoxin. Botulinum A, and E neurotoxins recognize and cleave specifically SNAP-25, a protein of the presynaptic membrane, at two different sites within the carboxyl-terminus. Botulinum neurotoxin type C cleaves syntaxin, another protein of the nerve plasmalemma. These results indicate that VAMP, SNAP-25 and syntaxin play a central role in neuroexocytosis. These three proteins are conserved from yeast to humans and are essential in a variety of docking and fusion events in every cell. Tetanus and botulinum neurotoxins form a new group of zinc-endopeptidases with characteristic sequence, mode of zinc coordination, mechanism of activation and target recognition. They will be of great value in the unravelling of the mechanisms of exocytosis and endocytosis, as they are in the clinical treatment of dystonias.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8771234     DOI: 10.1017/s0033583500003292

Source DB:  PubMed          Journal:  Q Rev Biophys        ISSN: 0033-5835            Impact factor:   5.318


  106 in total

1.  Fusion of endosomes involved in synaptic vesicle recycling.

Authors:  C Holroyd; U Kistner; W Annaert; R Jahn
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor.

Authors:  J Herreros; G Lalli; G Schiavo
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

3.  Syntaxin modulation of calcium channels in cortical synaptosomes as revealed by botulinum toxin C1.

Authors:  J B Bergsman; R W Tsien
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 4.  The kinetics of nerve-evoked quantal secretion.

Authors:  R Fesce
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

5.  Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display.

Authors:  B P Mullaney; M G Pallavicini; J D Marks
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Co-induction of LTP and LTD and its regulation by protein kinases and phosphatases.

Authors:  Kathryn B Grey; Brian D Burrell
Journal:  J Neurophysiol       Date:  2010-03-24       Impact factor: 2.714

7.  Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.

Authors:  Brent Segelke; Mark Knapp; Saloumeh Kadkhodayan; Rod Balhorn; Bernhard Rupp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

8.  In Vivo Toxicity and Immunological Characterization of Detoxified Recombinant Botulinum Neurotoxin Type A.

Authors:  Easwaran Ravichandran; Pavithra Janardhanan; Kruti Patel; Stephen Riding; Shuowei Cai; Bal Ram Singh
Journal:  Pharm Res       Date:  2015-11-03       Impact factor: 4.200

9.  Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.

Authors:  Roshan V Kukreja; Shashi K Sharma; Bal Ram Singh
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

10.  The identification and biochemical characterization of drug-like compounds that inhibit botulinum neurotoxin serotype A endopeptidase activity.

Authors:  Shuowei Cai; Paul Lindo; Jong-Beak Park; Kruti Vasa; Bal Ram Singh
Journal:  Toxicon       Date:  2009-12-07       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.